Navigation Links
SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results
Date:3/2/2009

Annual Royalty Revenue Increases 72% from Prior Year

DUBLIN, Calif., March 2 /PRNewswire-FirstCall/ -- SuperGen Inc., (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today reported financial results for the fourth quarter and year ended December 31, 2008.

The Company reported a net loss for the 2008 fourth quarter of $2.6 million, or $0.04 per share, compared with net income of $5.1 million, or $0.09 per share, for the same prior year period. The Company reported a net loss for the year ended December 31, 2008 of $9.1 million, or $0.16 per share, compared with net income of $13.1 million, or $0.23 per share, for the same prior year period.

Highlights for 2008 include:

  • Dacogen(R) (decitabine) for Injection royalty revenue was $38.4 million for 2008 compared to $22.3 million for 2007, an increase of 72% from the prior year.
  • The Company ended the year with unrestricted cash, cash equivalents, and current and non-current marketable securities totaling approximately $88.3 million.
  • The Company remained debt-free during 2008, and used approximately $1.7 million of net cash in operating activities during the year as compared to net cash used in operating activities of approximately $5.8 million in the prior year.
  • MP-470, a DNA repair suppressor, advanced in the clinic with Phase 1 and 1b data presented at several scientific forums.
  • The Company received clearance from the Food and Drug Administration, or FDA, to initiate clinical trials with SGI-1776, an inhibitor of PIM kinases.

"SuperGen continued to make significant progress during 2008 with advances in the clinic and in pre-clinical development and discovery o
'/>"/>

SOURCE SuperGen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. SuperGen to Announce 2008 Fourth Quarter and Fiscal Year-End Financial Results March 2, 2009
2. SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009
3. SuperGen to Present at the Lazard Capital Markets Fifth Annual Healthcare Conference on November 18, 2008
4. SuperGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 10, 2008
5. SuperGen to Present at the Collins Stewart Growth Conference on July 9, 2008
6. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
7. SuperGen Reports 2007 Third Quarter Financial Results
8. SuperGen to Announce 2007 Third Quarter Financial Results October 29, 2007
9. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
10. IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results
11. Claimsnet.com Reports Fiscal Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... LAFAYETTE, Ind. - Purdue University researchers have developed a ... living cell by using tiny gold particles with tails ... professor of agricultural and biological engineering, used gold nanoparticles ... known as BRCA1 messenger RNA splice variants, which can ... number of these mRNA splice variants in a cell ...
(Date:4/23/2014)... new computer program could help doctors predict which patients ... treatment. , The program, which assesses brain scans ... airport security and passport control, has been developed by ... study funded by the Wellcome Trust, which used the ... . , Stroke affects over 15 million people ...
(Date:4/23/2014)... as the United States, it may come as a surprise ... adequate food due to lack of money or other financial ... the University of Illinois using data from the National Health ... are dealing with hunger are also facing negative health and ... over age 60 faced the threat of hungerthat translates to ...
(Date:4/23/2014)... Oncotarget , explored tumour heterogeneity where different ... signatures within the same cancer. Such differences could ... strategies. , Firstly they confirmed the mutual exclusivity ... or BRAF mutation. Secondly, they found that lung ... that specific mutation present uniformly throughout the tumour, ...
(Date:4/22/2014)... New Jersey Institute of Technology (NJIT) today to ... launch of the New Jersey Innovation Institute (NJII), ... for business innovation through the leveraging of industry, ... Senator Cory Booker, Panasonic Corp. of North America ... Governor Kim Guadagno, New Jersey Secretary of Higher ...
Breaking Medicine News(10 mins):Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:More Americans in their golden years are going hungry 2Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2
... study found, , , WEDNESDAY, Feb. 11 (HealthDay News) -- Offering ... their unhealthy habit helps more people give up cigarettes, new ... issue of the New England Journal of Medicine , ... the country who were offered up to $750 to give ...
... 11 St. Mary-Corwin Medical Center joins Centura ... observe Heart Month throughout the month of February. ... consumer promotions to provide southern Colorado communities with ... the leading cause of death among Coloradans.Centura has ...
... Down from 2005 ProjectionsHARRISBURG, Pa., Feb. 11 The ... part, because of the efforts of the Pennsylvania Center ... Secretary Sandi Vito announced today. The information is included ... Nurse Workforce in Pennsylvania " and " The Licensed ...
... today by AARP Pennsylvania: WHO: AARP will host ... WHAT: Participants will express their views on how ... communities. And, they will hear from Senator Specter on ... problems under a new Administration and Congress. WHEN: ...
... have identified a new biological marker present in the ... the cancer is progressing and spreading. , In experiments ... journal Nature, the scientists identified 10 metabolites ... progresses. Their studies showed that one of these chemicals, ...
... of Generation-X say they feel unprepared for long-term care ... steps to prepare for their futures, according to a ... The survey, conducted by StrategyOne on behalf of AHIP, ... between 1960 and 1980 feel somewhat or entirely unprepared ...
Cached Medicine News:Health News:Promise of Cash Prompts Smokers to Quit 2Health News:Promise of Cash Prompts Smokers to Quit 3Health News:St. Mary-Corwin Medical Center and Centura Health Celebrate Heart Month 2Health News:St. Mary-Corwin Medical Center and Centura Health Celebrate Heart Month 3Health News:Work of PA Center for Health Careers Eases Pennsylvania's Nursing Shortage 2Health News:Survey of metabolites finds new prostate cancer marker 2Health News:Survey of metabolites finds new prostate cancer marker 3Health News:Generation-X Feels Unprepared for Long-Term Care Costs and the Future, Survey Finds 2Health News:Generation-X Feels Unprepared for Long-Term Care Costs and the Future, Survey Finds 3
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... report is available in its catalogue: ... and Technologies for Advanced Drug Delivery ... Administration http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
Ralk Hand Drill, with Jacobs chuck, wrench-locking, with axial channel for Kirschner wires, for twist drills up to 7 mm , for Kirschner wires up to 4 mm...
DeMartel (Bailey) Wire Saw Guide, 33 cm - 13, flexible....
Hudson brace only. Component parts and accessories for Hudson cranial drill....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Medicine Products: